Fundraising Fox
Rapafusyn
Baltimore, US · 2 known investors
Find your way into Rapafusyn
Sign up to see every warm intro you have to Rapafusyn
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Rapafusyn team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Rapafusyn develops molecular glue therapeutics using its RapaGlue platform of non-degrading macrocyclic compounds designed to modulate hard-to-drug intracellular and transmembrane protein targets. Its AI-enabled discovery approach and DNA-encoded library support an early-stage pipeline across oncology, immunology and inflammation, and renal disease, including a lead program in acute kidney injury.</parameter> <parameter name="hq_city">Baltimore
Founders & leadership
Investors · 2
How we know: 3E Bioventures Capital's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: funding news · Not right? Tell us
In the news
Frequently asked questions
- What does Rapafusyn do?
- Rapafusyn develops molecular glue therapeutics using its RapaGlue platform of non-degrading macrocyclic compounds designed to modulate hard-to-drug intracellular and transmembrane protein targets. Its AI-enabled discovery approach and DNA-encoded library support an early-stage pipeline across oncology, immunology and inflammation, and renal disease, including a lead program in acute kidney injury.</parameter> <parameter name="hq_city">Baltimore
- Who founded Rapafusyn?
- Rapafusyn was founded by Jun O. Liu.
- Who are Rapafusyn's investors?
- Rapafusyn's investors include 3E Bioventures Capital, BioTrack Capital.
- Where is Rapafusyn headquartered?
- Rapafusyn is headquartered in Baltimore, US.